MUSK and myasthenia gravis: MuSK-Ab-positive MG usually presents with more severe clinical symptoms and is less sensitive to treatment compared to AChR antibody-positive MG (Guptill et al., 2011; Chang et al., 2014; Gilhus and Verschuuren, 2015).